Invalidity dossier
US 4795699
T7 DNA polymerase
Current assignee: Harvard University
Added 9/23/2026, 8:45:34 PM
Active provider: DeepSeek · deepseek-flash
Patent summary
Title, assignee, inventors, filing/issue dates, abstract, and a plain-language overview of the claims.
Patent Overview: US4795699A — "T7 DNA polymerase"
Bibliographic data (from supplied text)
- Patent number: US4795699A
- Title: T7 DNA polymerase
- Inventors: Stanley Tabor; Charles C. Richardson
- Original/current assignee: Harvard University (assigned to President and Fellows of Harvard College, a charitable corp.)
- Application number: US07/003,227
- Priority date / filing date: 1987-01-14
- Publication (grant) date: 1989-01-03
- Legal status: Expired – Lifetime; anticipated expiration 2007-01-14
Purpose and plain-language scope
The patent concerns T7 DNA polymerase and methods involving it. The keyword and classification data indicate the disclosure centers on DNA polymerase, DNA, exonuclease, nucleotides/triphosphates, primers, and DNA sequencing, including chain-termination-type sequencing using dideoxynucleotides and dITP. The description references reagents and conditions such as dATP, dGTP, thioredoxin, dithiothreitol, sodium chloride, EDTA, glycerol, and incubation/annealing steps.
In plain terms, the patent appears directed to a T7 DNA polymerase preparation and to methods of using it to synthesize DNA from a primer on a template, with applications in DNA sequencing. The excerpt's prior-art keywords (polymerase, DNA, reaction, primer, gene) are consistent with this focus.
What the excerpt does not establish
The supplied text includes bibliographic, family, litigation-link, and keyword/classification data, but not the actual claims, abstract, or full description. Therefore this overview cannot state the precise claimed scope, claim limitations, dependencies, or the specific novelty asserted over prior art. It also does not establish enablement details, exact reagent concentrations, or the full experimental protocols.
Per operating instructions, no litigation, ownership-transfer, validity, or prior-art analysis is offered here.
Source: https://patents.google.com/patent/[US4795699](/patent/US4795699)/en
Generated 10/1/2026, 9:41:12 PM
Cases on file (0)
Specific litigation cases in our database that name US patent 4795699. The free-form analysis below may also discuss cases beyond this list.
No cases on file mention this patent. Upload a CSV or add a case manually in Admin → Manage litigation cases.
Litigation summary
Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.
Proceedings on file (0)
All PTAB activity →AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.
No PTAB proceedings on file. This patent has not been challenged via IPR, PGR, or CBM. The absence is itself a signal — well-asserted patents eventually attract IPRs. The LLM analysis below may surface filings the ODP feed hasn’t indexed yet.
PTAB challenges
AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.
Assignment history
Inventors, original assignee, and the chain of ownership recorded with the USPTO — including the correspondent attorney who recorded each assignment, since shell-LLC chains often share one repeat-player attorney even when the entity names look unrelated. Surfaces NPE / patent-troll patterns: shell-entity transfers, known asserters in the chain, repeat correspondent fingerprints, pre-litigation assignments, and bankruptcy fire-sales.
Prior art
Earlier patents, publications, and products that may anticipate or render the claims unpatentable.
Obviousness
Combinations of prior art that suggest the claimed invention would have been obvious under 35 U.S.C. § 103.
Extensions
Patent term adjustments, term extensions, continuations, divisionals, family members, and expiration dates.
Derivative works
Defensive disclosure: derivative variations of each claim designed to render future incremental improvements obvious or non-novel.